Browsing "1. Journal Papers" by Author : 4229

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 118 to 177 of 432

This table browses all dspace content
Issue DateTitleJournal Title
2017Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab ONCOTARGET
2021Detection of asymptomatic recurrence improves survival of gastric cancer patients CANCER MEDICINE
2005Determination of genes related to gastrointestinal tract origin cancer cells using a cDNA microarray CLINICAL CANCER RESEARCH
2021Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population GUT
2019Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue SarcomaOncology
2007Different criteria for HER2 positivity by IHC can be applied in post-chemotherapy specimens in determining HER2 as a prognosticator in locally advanced breast cancerBREAST CANCER RESEARCH AND TREATMENT
1998Different expression patterns of MMP-2 and MMP-9 in breast cancerONCOLOGY REPORTS
2005Different role of functional domains of hTR in DNA binding to telomere and telomerase reconstruction FEBS LETTERS
2017Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia ANNALS OF SURGERY
2024Discovery of novel 1H-benzo[d]imidazole-4,7-dione based transglutaminase 2 inhibitors as p53 stabilizing anticancer agents in renal cell carcinomaBIOORGANIC CHEMISTRY
2008Disease Prediction Using Ranks of Gene Expressions Genomics & Informatics
2011DNA methylation predicts recurrence from resected stage III proximal colon cancer CANCER
2015Do Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence? MEDICINE
2009Docetaxel versus paclitaxel combined with 5-FU and leucovorin in advanced gastric cancer: combined analysis of two phase II trials. CANCER RESEARCH AND TREATMENT
2015Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of KRAS or BRAF mutation status in colorectal cancer AMERICAN JOURNAL OF CANCER RESEARCH
2016Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.EXPERIMENTAL AND MOLECULAR PATHOLOGY
2001Early Postoperative Intraperitoneal Chemotherapy with Mitomycin C, 5-Fluorouracil and Cisplatin for Advanced Gastric CancerONCOLOGY
2009Effect of being overweight on postoperative morbidity and long-term surgical outcomes in proximal gastric carcinomaJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2019Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical TrialJAMA Network Open
2017Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancerBREAST CANCER RESEARCH AND TREATMENT
1999Effects of interleukin-2 transduction on the human hepatoma cell lines using retroviral vectorONCOLOGY REPORTS
2010Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinomaINTERNATIONAL JOURNAL OF HYPERTHERMIA
2018Efficacy and Safety of Ixabepilone and Capecitabine in Patients With Advanced Triple-negative Breast Cancer: a Pooled Analysis From Two Large Phase III, Randomized Clinical TrialsCLINICAL BREAST CANCER
2022Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors NEURO-ONCOLOGY
2020Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studiesINTERNATIONAL JOURNAL OF CANCER
2019Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 StudyJOURNAL OF CLINICAL ONCOLOGY
2018Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: Pooled analyses after long-term follow-up in KEYNOTE-012BRITISH JOURNAL OF CANCER
2023Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 studyCANCER
2020Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical TrialJAMA ONCOLOGY
2020Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 StudyJOURNAL OF CLINICAL ONCOLOGY
2021Efficacy of Pembrolizumab Monotherapy for Advanced Gastric/Gastroesophageal Junction Cancer with Programmed Death Ligand 1 Combined Positive Score ≥10 CLINICAL CANCER RESEARCH
2001Efficacy of Pre - and Postoperative Chemotherapy in Patients with Osteosarcoma of the Extremities CANCER RESEARCH AND TREATMENT
2007Entropy-based analysis of the non-linear relationship between gene expression profiles of amplified and non-amplified RNAINTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
2012Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research GroupJOURNAL OF CLINICAL ONCOLOGY
2013Estimating the Adjuvant Chemotherapy Effect in Elderly Stage II and III Colon Cancer Patients in an Observational StudyJOURNAL OF SURGICAL ONCOLOGY
2022Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study EUROPEAN JOURNAL OF CANCER
2012Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients: a multicenter, cross-sectional studyASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
2013Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 StudyJOURNAL OF CLINICAL ONCOLOGY
2022Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancerJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2021Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion studyLANCET ONCOLOGY
2022Exploratory analysis of the impact of prior immune checkpoint inhibitor (ICI) on trastuzumab deruxtecan (T-DXd; DS-8201) clinical outcomes and biomarkers (BM) in DESTINY-Gastric01 (DG-01), a randomized, phase 2, multicenter, open-label study in patients (pts) with HER2+ advanced gastric or gastroesophageal junction adenocarcinomaJOURNAL OF CLINICAL ONCOLOGY
2020Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer GASTRIC CANCER
2009Expression of anaphase-promoting complex7 in fibroadenomas and phyllodes tumors of breastHUMAN PATHOLOGY
2004Fabrication of high quality cDNA microarray using a small amount of cDNAINTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
2017Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer CLINICAL EPIGENETICS
2024First-in-Human Phase 1 Study of a B Cell- and Monocyte-Based Immunotherapeutic Vaccine Against HER2-Positive Advanced Gastric Cancer CANCER RESEARCH AND TREATMENT
2022First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer ANNALS OF ONCOLOGY
2021First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811 FUTURE ONCOLOGY
2012FKBP5 polymorphisms as vulnerability to anxiety and depression in patients with advanced gastric cancer: a controlled and prospective studyPSYCHONEUROENDOCRINOLOGY
2018Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitorINTERNATIONAL JOURNAL OF CANCER
2009G-T haplotype (2677G>T/A and 3435C>T) of ABCB1 gene polymorphisms is associated with ethnic differences to paclitaxel sensitivity in cancer cells with different gene expression patternCANCER LETTERS
1996Gastric Cancer in Young Patients Who Underwent Curative Resection: Comparative Study with Older PatientsAMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
2007Gastrointestinal stromal tumor of the rectum: An analysis of seven casesSURGERY TODAY
2005Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancerBREAST CANCER RESEARCH AND TREATMENT
2005Gene copy number change events at chromosome 20 and their association with recurrence in gastric cancer patients CLINICAL CANCER RESEARCH
2020Gene Expression Profiling Identifies Akt as a Target for Radiosensitization in Gastric Cancer Cells FRONTIERS IN ONCOLOGY
2016Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites ONCOTARGET
2009Genetic and epigenetic marker-based DNA test of stool is a promising approach for colorectal cancer screening YONSEI MEDICAL JOURNAL
2003Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarrayINTERNATIONAL JOURNAL OF ONCOLOGY
2007Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization BMC GENOMICS

Browse

Links